Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Researchers 3D print hearts to improve LAA operations
Researchers in Australia are creating 3D replicas of patient’s hearts to plan out left atrial appendage closures using Boston Scientific‘s Watchman device, according to a new report from heartwire.
Creating the 3D replica is useful in patients with complicated cardiovascular anatomy, where even advanced imaging methods can make it difficult to quantify the area of the appendage, researchers told heartwire. Read more
2. Echo Therapeutics breaks lease on Mass. lab space
Echo Therapeutics said it is moving its research lab from Franklin, Mass. to Littleton, Mass. and terminating its previous lease in the process.
The Philadelphia-based developer of wireless glucose monitors and wearable health and fitness devices said it paid $150,000 to break the lease on its previous 37,050 square foot research facility in Franklin. Read more
1. FDA wants more from Edap on Ablatherm de novo bid
Edap said the FDA wants more on its bid for de novo approval of its Ablatherm HIFU prostate cancer device, saying it needs to address 4 points raised by the federal safety watchdog before the process can resume.
The news, following the French firm’s March announcement that it would abandon its pre-market approval application, sent EDAP shares up 7.5% to $3.75 apiece in pre-market trading today. The stock opened at $3.52 per share and was trading at $3.47 shortly after trading commenced. Read more
The post MassDevice.com +3 | The top 3 medtech stories for July 21, 2015 appeared first on MassDevice.
from MassDevice http://ift.tt/1IiBKlE
Cap comentari:
Publica un comentari a l'entrada